Edition:
United Kingdom

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

6.99USD
8:59pm GMT
Change (% chg)

$-0.15 (-2.10%)
Prev Close
$7.14
Open
$7.23
Day's High
$7.31
Day's Low
$6.81
Volume
150,893
Avg. Vol
193,332
52-wk High
$8.30
52-wk Low
$4.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.22 December 14 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 3 3 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 2.93 4.08 0.00 2.75
Year Ending Dec-18 8 22.87 37.00 18.00 20.33
Year Ending Dec-19 8 10.62 17.76 0.10 21.20
Earnings (per share)
Quarter Ending Dec-18 8 -0.22 -0.12 -0.27 -0.20
Year Ending Dec-18 8 -0.94 -0.76 -1.02 -0.76
Year Ending Dec-19 8 -1.01 -0.89 -1.10 -0.76

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 3.98 1.45 2.52 63.45
Quarter Ending Jun-18 3.52 12.49 8.97 254.75
Quarter Ending Mar-18 6.04 3.98 2.06 34.16
Quarter Ending Dec-17 4.93 3.89 1.04 21.03
Quarter Ending Sep-17 4.62 8.76 4.14 89.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2.93 3.55 4.42 4.99 2.75
Year Ending Dec-18 22.87 25.70 26.93 26.84 20.33
Year Ending Dec-19 10.62 12.03 14.68 17.84 21.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 3 2 2 5
Year Ending Dec-18 4 3 2 5
Year Ending Dec-19 3 4 1 6
Earnings